Global Diabetic Retinopathy Market Research Report 2026(Status And Outlook)

Buy Now
Share to
Facebook
Twitter
LinkedIn
WhatsApp
Base Year
2026
Forecast Period
2024-2029
Pages
139
Industry
Medical Devices
Regions
Global
Updated
February 2026

Report Overview


Report Overview
Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease.According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

The global Diabetic Retinopathy market size was estimated at USD 8766.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.20% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Diabetic Retinopathy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Diabetic Retinopathy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Diabetic Retinopathy market.
Global Diabetic Retinopathy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bayer
Roche
Novartis
TEVA
Alimera Sciences
Regeneron Pharmaceuticals
Boehringer Ingelheim
Kowa Group
Ohr Pharmaceutical
Quark Pharmaceuticals

Market Segmentation (by Type)
Laser Surgery
Injection of Corticosteroids
Anti-VEGF Drugs
Vitrectomy

Market Segmentation (by Application)
Hospitals
Clinics
Others

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Diabetic Retinopathy Market
Overview of the regional outlook of the Diabetic Retinopathy Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Diabetic Retinopathy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Diabetic Retinopathy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



Table of Contents

  • 1 Research Methodology and Statistical Scope
    • 1.1 Market Definition and Statistical Scope of Diabetic Retinopathy
    • 1.2 Key Market Segments
      • 1.2.1 Diabetic Retinopathy Segment by Type
      • 1.2.2 Diabetic Retinopathy Segment by Application
    • 1.3 Methodology & Sources of Information
      • 1.3.1 Research Methodology
      • 1.3.2 Research Process
      • 1.3.3 Market Breakdown and Data Triangulation
      • 1.3.4 Base Year
      • 1.3.5 Report Assumptions & Caveats
  • 2 Diabetic Retinopathy Market Overview
    • 2.1 Global Market Overview
      • 2.1.1 Global Diabetic Retinopathy Market Size (M USD) Estimates and Forecasts (2020-2035)
      • 2.1.2 Global Diabetic Retinopathy Sales Estimates and Forecasts (2020-2035)
    • 2.2 Market Segment Executive Summary
    • 2.3 Global Market Size by Region
  • 3 Diabetic Retinopathy Market Competitive Landscape
    • 3.1 Company Assessment Quadrant
    • 3.2 Global Diabetic Retinopathy Product Life Cycle
    • 3.3 Global Diabetic Retinopathy Sales by Manufacturers (2020-2025)
    • 3.4 Global Diabetic Retinopathy Revenue Market Share by Manufacturers (2020-2025)
    • 3.5 Diabetic Retinopathy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.6 Global Diabetic Retinopathy Average Price by Manufacturers (2020-2025)
    • 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
    • 3.8 Diabetic Retinopathy Market Competitive Situation and Trends
      • 3.8.1 Diabetic Retinopathy Market Concentration Rate
      • 3.8.2 Global 5 and 10 Largest Diabetic Retinopathy Players Market Share by Revenue
      • 3.8.3 Mergers & Acquisitions, Expansion
  • 4 Diabetic Retinopathy Industry Chain Analysis
    • 4.1 Diabetic Retinopathy Industry Chain Analysis
    • 4.2 Market Overview of Key Raw Materials
    • 4.3 Midstream Market Analysis
    • 4.4 Downstream Customer Analysis
  • 5 The Development and Dynamics of Diabetic Retinopathy Market
    • 5.1 Key Development Trends
    • 5.2 Driving Factors
    • 5.3 Market Challenges
    • 5.4 Industry News
      • 5.4.1 New Product Developments
      • 5.4.2 Mergers & Acquisitions
      • 5.4.3 Expansions
      • 5.4.4 Collaboration/Supply Contracts
    • 5.5 PEST Analysis
      • 5.5.1 Industry Policies Analysis
      • 5.5.2 Economic Environment Analysis
      • 5.5.3 Social Environment Analysis
      • 5.5.4 Technological Environment Analysis
    • 5.6 Global Diabetic Retinopathy Market Porters Five Forces Analysis
      • 5.6.1 Global Trade Frictions
      • 5.6.2 U.S. Tariff Policy – April 2025
      • 5.6.3 Global Trade Frictions and Their Impacts to Diabetic Retinopathy Market
    • 5.7 ESG Ratings of Leading Companies
  • 6 Diabetic Retinopathy Market Segmentation by Type
    • 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    • 6.2 Global Diabetic Retinopathy Sales Market Share by Type (2020-2025)
    • 6.3 Global Diabetic Retinopathy Market Size by Type (2020-2025)
    • 6.4 Global Diabetic Retinopathy Price by Type (2020-2025)
  • 7 Diabetic Retinopathy Market Segmentation by Application
    • 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    • 7.2 Global Diabetic Retinopathy Market Sales by Application (2020-2025)
    • 7.3 Global Diabetic Retinopathy Market Size (M USD) by Application (2020-2025)
    • 7.4 Global Diabetic Retinopathy Sales Growth Rate by Application (2020-2025)
  • 8 Diabetic Retinopathy Market Sales by Region
    • 8.1 Global Diabetic Retinopathy Sales by Region
      • 8.1.1 Global Diabetic Retinopathy Sales by Region
      • 8.1.2 Global Diabetic Retinopathy Sales Market Share by Region
    • 8.2 Global Diabetic Retinopathy Market Size by Region
      • 8.2.1 Global Diabetic Retinopathy Market Size by Region
      • 8.2.2 Global Diabetic Retinopathy Market Size by Region
    • 8.3 North America
      • 8.3.1 North America Diabetic Retinopathy Sales by Country
      • 8.3.2 North America Diabetic Retinopathy Market Size by Country
      • 8.3.3 U.S. Market Overview
      • 8.3.4 Canada Market Overview
      • 8.3.5 Mexico Market Overview
    • 8.4 Europe
      • 8.4.1 Europe Diabetic Retinopathy Sales by Country
      • 8.4.2 Europe Diabetic Retinopathy Market Size by Country
      • 8.4.3 Germany Market Overview
      • 8.4.4 France Market Overview
      • 8.4.5 U.K. Market Overview
      • 8.4.6 Italy Market Overview
      • 8.4.7 Spain Market Overview
    • 8.5 Asia Pacific
      • 8.5.1 Asia Pacific Diabetic Retinopathy Sales by Region
      • 8.5.2 Asia Pacific Diabetic Retinopathy Market Size by Region
      • 8.5.3 China Market Overview
      • 8.5.4 Japan Market Overview
      • 8.5.5 South Korea Market Overview
      • 8.5.6 India Market Overview
      • 8.5.7 Southeast Asia Market Overview
    • 8.6 South America
      • 8.6.1 South America Diabetic Retinopathy Sales by Country
      • 8.6.2 South America Diabetic Retinopathy Market Size by Country
      • 8.6.3 Brazil Market Overview
      • 8.6.4 Argentina Market Overview
      • 8.6.5 Columbia Market Overview
    • 8.7 Middle East and Africa
      • 8.7.1 Middle East and Africa Diabetic Retinopathy Sales by Region
      • 8.7.2 Middle East and Africa Diabetic Retinopathy Market Size by Region
      • 8.7.3 Saudi Arabia Market Overview
      • 8.7.4 UAE Market Overview
      • 8.7.5 Egypt Market Overview
      • 8.7.6 Nigeria Market Overview
      • 8.7.7 South Africa Market Overview
  • 9 Diabetic Retinopathy Market Production by Region
    • 9.1 Global Production of Diabetic Retinopathy by Region(2020-2025)
    • 9.2 Global Diabetic Retinopathy Revenue Market Share by Region (2020-2025)
    • 9.3 Global Diabetic Retinopathy Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.4 North America Diabetic Retinopathy Production
      • 9.4.1 North America Diabetic Retinopathy Production Growth Rate (2020-2025)
      • 9.4.2 North America Diabetic Retinopathy Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.5 Europe Diabetic Retinopathy Production
      • 9.5.1 Europe Diabetic Retinopathy Production Growth Rate (2020-2025)
      • 9.5.2 Europe Diabetic Retinopathy Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.6 Japan Diabetic Retinopathy Production (2020-2025)
      • 9.6.1 Japan Diabetic Retinopathy Production Growth Rate (2020-2025)
      • 9.6.2 Japan Diabetic Retinopathy Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.7 China Diabetic Retinopathy Production (2020-2025)
      • 9.7.1 China Diabetic Retinopathy Production Growth Rate (2020-2025)
      • 9.7.2 China Diabetic Retinopathy Production, Revenue, Price and Gross Margin (2020-2025)
  • 10 Key Companies Profile
    • 10.1 Bayer
      • 10.1.1 Bayer Basic Information
      • 10.1.2 Bayer Diabetic Retinopathy Product Overview
      • 10.1.3 Bayer Diabetic Retinopathy Product Market Performance
      • 10.1.4 Bayer Business Overview
      • 10.1.5 Bayer SWOT Analysis
      • 10.1.6 Bayer Recent Developments
    • 10.2 Roche
      • 10.2.1 Roche Basic Information
      • 10.2.2 Roche Diabetic Retinopathy Product Overview
      • 10.2.3 Roche Diabetic Retinopathy Product Market Performance
      • 10.2.4 Roche Business Overview
      • 10.2.5 Roche SWOT Analysis
      • 10.2.6 Roche Recent Developments
    • 10.3 Novartis
      • 10.3.1 Novartis Basic Information
      • 10.3.2 Novartis Diabetic Retinopathy Product Overview
      • 10.3.3 Novartis Diabetic Retinopathy Product Market Performance
      • 10.3.4 Novartis Business Overview
      • 10.3.5 Novartis SWOT Analysis
      • 10.3.6 Novartis Recent Developments
    • 10.4 TEVA
      • 10.4.1 TEVA Basic Information
      • 10.4.2 TEVA Diabetic Retinopathy Product Overview
      • 10.4.3 TEVA Diabetic Retinopathy Product Market Performance
      • 10.4.4 TEVA Business Overview
      • 10.4.5 TEVA Recent Developments
    • 10.5 Alimera Sciences
      • 10.5.1 Alimera Sciences Basic Information
      • 10.5.2 Alimera Sciences Diabetic Retinopathy Product Overview
      • 10.5.3 Alimera Sciences Diabetic Retinopathy Product Market Performance
      • 10.5.4 Alimera Sciences Business Overview
      • 10.5.5 Alimera Sciences Recent Developments
    • 10.6 Regeneron Pharmaceuticals
      • 10.6.1 Regeneron Pharmaceuticals Basic Information
      • 10.6.2 Regeneron Pharmaceuticals Diabetic Retinopathy Product Overview
      • 10.6.3 Regeneron Pharmaceuticals Diabetic Retinopathy Product Market Performance
      • 10.6.4 Regeneron Pharmaceuticals Business Overview
      • 10.6.5 Regeneron Pharmaceuticals Recent Developments
    • 10.7 Boehringer Ingelheim
      • 10.7.1 Boehringer Ingelheim Basic Information
      • 10.7.2 Boehringer Ingelheim Diabetic Retinopathy Product Overview
      • 10.7.3 Boehringer Ingelheim Diabetic Retinopathy Product Market Performance
      • 10.7.4 Boehringer Ingelheim Business Overview
      • 10.7.5 Boehringer Ingelheim Recent Developments
    • 10.8 Kowa Group
      • 10.8.1 Kowa Group Basic Information
      • 10.8.2 Kowa Group Diabetic Retinopathy Product Overview
      • 10.8.3 Kowa Group Diabetic Retinopathy Product Market Performance
      • 10.8.4 Kowa Group Business Overview
      • 10.8.5 Kowa Group Recent Developments
    • 10.9 Ohr Pharmaceutical
      • 10.9.1 Ohr Pharmaceutical Basic Information
      • 10.9.2 Ohr Pharmaceutical Diabetic Retinopathy Product Overview
      • 10.9.3 Ohr Pharmaceutical Diabetic Retinopathy Product Market Performance
      • 10.9.4 Ohr Pharmaceutical Business Overview
      • 10.9.5 Ohr Pharmaceutical Recent Developments
    • 10.10 Quark Pharmaceuticals
      • 10.10.1 Quark Pharmaceuticals Basic Information
      • 10.10.2 Quark Pharmaceuticals Diabetic Retinopathy Product Overview
      • 10.10.3 Quark Pharmaceuticals Diabetic Retinopathy Product Market Performance
      • 10.10.4 Quark Pharmaceuticals Business Overview
      • 10.10.5 Quark Pharmaceuticals Recent Developments
  • 11 Diabetic Retinopathy Market Forecast by Region
    • 11.1 Global Diabetic Retinopathy Market Size Forecast
    • 11.2 Global Diabetic Retinopathy Market Forecast by Region
      • 11.2.1 North America Market Size Forecast by Country
      • 11.2.2 Europe Diabetic Retinopathy Market Size Forecast by Country
      • 11.2.3 Asia Pacific Diabetic Retinopathy Market Size Forecast by Region
      • 11.2.4 South America Diabetic Retinopathy Market Size Forecast by Country
      • 11.2.5 Middle East and Africa Forecasted Sales of Diabetic Retinopathy by Country
  • 12 Forecast Market by Type and by Application (2026-2035)
    • 12.1 Global Diabetic Retinopathy Market Forecast by Type (2026-2035)
      • 12.1.1 Global Forecasted Sales of Diabetic Retinopathy by Type (2026-2035)
      • 12.1.2 Global Diabetic Retinopathy Market Size Forecast by Type (2026-2035)
      • 12.1.3 Global Forecasted Price of Diabetic Retinopathy by Type (2026-2035)
    • 12.2 Global Diabetic Retinopathy Market Forecast by Application (2026-2035)
      • 12.2.1 Global Diabetic Retinopathy Sales (K Units) Forecast by Application
      • 12.2.2 Global Diabetic Retinopathy Market Size (M USD) Forecast by Application (2026-2035)
  • 13 Conclusion and Key Findings

Frequently Asked Questions

JSB Market Research is a global provider of market research reports, industry insights, and business intelligence solutions. We help companies, analysts, and decision-makers gain a deeper understanding of global and regional markets.

Our reports deliver data-driven insights, market opportunities, competitive landscapes, and future forecasts. These help your business make informed decisions, enter new markets confidently, and stay ahead of industry trends.

Yes. We offer tailored research services designed to meet your specific market, product, or competitor analysis needs. Our experts work closely with clients to deliver precise, relevant, and actionable insights.

Browse the desired report, select your preferred license type, and complete payment through our secure checkout. For corporate purchases or invoice payments, you can contact our support team directly.

Yes. You can request sample pages or a report overview. This helps you understand the structure, methodology, and depth of analysis before purchasing.